Start:
March 2, 2020
End:
March 2024
Enrollment:
40
This study will test the effects of repetitive transcranial magnetic stimulation (rTMS), a noninvasive brain stimulation therapy, on cognitively healthy older adults and in people with amnestic mild cognitive impairment due to Alzheimer's disease. The intervention is designed to improve cognition, including memory, in older adults. All study participants will receive the rTMS intervention followed by a functional connectivity MRI to determine any changes in the brain. Participants will also undergo neuropsychological and memory testing to determine improvements in cognition.
Minimum Age: 60 Years
Maximum Age: 85 Years
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Massachusetts | |
---|---|
Massachuetts General Hospital
Charlestown,
MA
02129
Recruiting
Courtney Sullivan |
Lead: Massachusetts General Hospital
Source: ClinicalTrials.gov ID: NCT04294888
An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health